Cholangiocarcinoma

被引:1103
作者
Khan, SA
Thomas, HC
Davidson, BR
Taylor-Robinson, SD
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Med, Liver Unit, London, England
[2] Royal Free Hosp, Dept Surg, London NW3 2QG, England
关键词
D O I
10.1016/S0140-6736(05)67530-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to diagnose, and is associated with a high mortality. The incidence of intrahepatic cholangiocarcinoma is increasing worldwide. The cause for this rise is unclear, although it could be related to an interplay between predisposing genetic factors and environmental triggers. MRI and CT with endoscopic ultrasound and PET provide useful diagnostic information in certain patients. Surgical resection is the only chance for cure, with results depending on careful technique and patient selection. Data suggest that liver transplantation could offer long-term survival in selected patients when combined with neoadjuvant chemoradiotherapy. Chemotherapy and radiotherapy have been ineffective for patients with inoperable tumours. For most of these patients biliary drainage is the mainstay of palliation. However, controversy exists over the type and positioning of biliary stents. Photodynamic treatment is a new palliative technique that might improve quality of life.
引用
收藏
页码:1303 / 1314
页数:12
相关论文
共 129 条
  • [101] The epidemiology of cholangiocarcinoma
    Shaib, Y
    El-Serag, HB
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 (02) : 115 - 125
  • [102] Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
    Shaib, YH
    El-Serag, HB
    Davila, JA
    Morgan, R
    McGlynn, KA
    [J]. GASTROENTEROLOGY, 2005, 128 (03) : 620 - 626
  • [103] Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
    Shaib, YH
    Davila, JA
    McGlynn, K
    El-Serag, HB
    [J]. JOURNAL OF HEPATOLOGY, 2004, 40 (03) : 472 - 477
  • [104] Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: A case-control study in Pusan, Korea
    Shin, HR
    Lee, CU
    Park, HJ
    Seol, SY
    Chung, JM
    Choi, HC
    Ahn, YO
    Shigemastu, T
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (05) : 933 - 940
  • [105] Simeone D., 1999, TXB GASTROENTEROLOGY, P2244
  • [106] Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis
    Siqueira, E
    Schoen, RE
    Silverman, W
    Martini, J
    Rabinovitz, M
    Weissfeld, JL
    Abu Elmaagd, K
    Madariaga, JR
    Slivka, A
    [J]. GASTROINTESTINAL ENDOSCOPY, 2002, 56 (01) : 40 - 47
  • [107] Risk of liver and other types of cancer in patients with cirrhosis:: A nationwide cohort study in Denmark
    Sorensen, HT
    Friis, S
    Olsen, JH
    Thulstrup, M
    Mellemkjær, L
    Linet, M
    Trichopoulos, D
    Vilstrup, H
    Olsen, J
    [J]. HEPATOLOGY, 1998, 28 (04) : 921 - 925
  • [108] Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma
    Su, CH
    Tsay, SH
    Wu, CC
    Shyr, YM
    King, KL
    Lee, CH
    Lui, WY
    Liu, TJ
    Peng, FK
    [J]. ANNALS OF SURGERY, 1996, 223 (04) : 384 - 394
  • [109] Are covered stents superior to uncovered stents in the management of malignant biliary obstruction?
    Sung, Joseph
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (01): : 20 - 21
  • [110] P16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholanglocarcinoma
    Taniai, M
    Higuchi, H
    Burgart, LJ
    Gores, GJ
    [J]. GASTROENTEROLOGY, 2002, 123 (04) : 1090 - 1098